Treatment Against Lethal Marburg Virus Developed
Thursday, August 21, 2014 - 20:10
in Health & Medicine
Tekmira Pharmaceuticals and collaborators at the University of Texas Medical Branch at Galveston, have protected nonhuman primates against Marburg virus, also known as Angola hemorrhagic fever. There are currently no vaccines or drugs approved for human use and no post-exposure treatment that has completely protected nonhuman primates against MARV-Angola, the most deadly Marburg viral strain, with a mortality rate of up to 90 percent. This virus, which is in the same family as Ebola, has a rapid disease course (seven to nine days) in nonhuman primates. There have been two recent imported cases of MARV HF to Europe and the United States, further increasing concern regarding the public health threat posed by this deadly virus. read more